Today: 8 June 2026
India stock market today: Nifty tops 25,900 again as foreign inflows and trade deal buzz linger

India stock market today: Nifty tops 25,900 again as foreign inflows and trade deal buzz linger

Mumbai, Feb 10, 2026, 16:09 IST — After-hours.

  • Benchmarks closed higher for a third straight session, with gains led by autos and metals.
  • Traders kept an eye on foreign buying signals and the interim India–U.S. trade framework.
  • Inflation data later this week is the next near-term test for rates and risk appetite.

Indian equity benchmarks inched up for a third straight session on Tuesday, with the Nifty 50 closing 0.26% higher at 25,935.15 and the Sensex gaining 0.25% to 84,273.92. Auto stocks rose 1.4% and metals added 0.8%, while exchange operator BSE jumped 6.3% on quarterly results and Ramco Cements slid 3% after its numbers failed to impress. “Improving sentiment around renewed foreign inflows, strength in U.S. markets, and optimism surrounding the interim India–U.S. trade framework are providing near-term support,” said Aakash Shah, technical research analyst at Choice Equity Broking. Foreign portfolio investors, overseas funds that trade Indian stocks, bought 22.55 billion rupees’ worth of shares on Monday, provisional data showed. Reuters

The grind higher matters because the last few months have trained traders to treat foreign money as the swing vote. This week, the market is trying to decide if the bounce is just positioning after a drawdown, or the start of something stickier.

Broader shares again did a bit more work than the benchmarks, with midcap and smallcap indices rising 0.5% and 0.35%, respectively. Eternal rose more than 5% and Tata Steel gained 2.82% on the Sensex, while HCL Tech, Bajaj Finance and Bharti Airtel fell up to 2%. Vinod Nair, head of research at Geojit Investments, said the rise was helped by the U.S. trade agreement and firmer Asian cues, though he flagged intermittent profit-booking and said the near-term trajectory will hinge on mixed third-quarter earnings.

Monday’s session set the tone. The Nifty rose 0.68% and the Sensex added 0.58%, with State Bank of India jumping 7.5% to a record high after it beat quarterly profit estimates and raised its full-year loan growth outlook. Export-linked pockets such as textiles, seafood, jewellery and aerospace suppliers also climbed after India and the United States released an interim trade framework that would lower tariffs, reshape energy ties and deepen economic cooperation. “The interim trade framework is a sentimental positive for markets,” said Dharmesh Kant, head of equity research at Cholamandalam Securities. Reuters

The rupee closed 18 paise stronger at 90.58 per dollar, adding another tailwind for sentiment in late trade. Dilip Parmar, a research analyst at HDFC Securities, said the currency’s rise tracked a softer U.S. dollar and was reinforced by overseas funds turning net buyers; he expects USD/INR, the dollar/rupee pair, to consolidate between 90.05 and 91.10.

Technicals are starting to creep back into the conversation after the quick three-day climb. Shrikant Chouhan, head of equity research at Kotak Securities, said a slip below 25,900 on the Nifty (84,100 on the Sensex) could trigger a quick intraday dip toward 25,800–25,750, while 26,000 on the Nifty (84,500 on the Sensex) sits as immediate resistance.

But there is an obvious risk: the rally is leaning on foreign inflows and a trade narrative that still needs hard details. If earnings keep missing expectations or global rates reprice on inflation surprises, the market could struggle to hold the recent breakout levels.

Next up is inflation. India is due to publish a revised CPI series (base 2024=100) on Thursday, and the United States is scheduled to release January CPI on Friday — prints that could reset rate bets and spill straight into equities.

Stock Market Today

  • Indian Stock Market July 8: Cautious Start Amid Middle East Tensions
    June 8, 2026, 9:21 AM EDT. Indian stocks are poised for a cautious open on June 8, impacted by rising Middle East tensions and a global market selloff. The GIFT Nifty index fell over 1%, as Asian markets including South Korea and Japan declined sharply, signaling increased investor risk aversion. Higher crude oil prices and a rebound in gold indicate a shift towards defensive assets. Investors will watch key domestic developments in companies like TVS Motor, RailTel, KNR Constructions, Creative Newtech, Amber Enterprises, and Ixigo. Fundraising activities at Zee, ASM Technologies, and Gujarat Themis, along with regulatory issues at Yes Bank, 5Paisa, and Reliance Infrastructure, will also remain in focus.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results
Previous Story

BAT share price slips again as buyback filing lands and Capital Group trims stake ahead of results

Legal & General share price slips as AI disruption worries keep UK insurers on edge
Next Story

Legal & General share price slips as AI disruption worries keep UK insurers on edge

Go toTop